rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    SLP
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Simulations Plus partners with pharma firm on AI drug modeling
      Oct 8Investing.comSLP
      Simulations Plus Announces Funded Partnership with Global Pharmaceutical Company to Advance AI-Enabled QSP Model Development with Turin
      Oct 8Yahoo FinanceSLP
      Altaris Completes Acquisition of Simulations Plus
      Oct 6Yahoo FinanceSLP
      Simulations Plus Announces Completion of Acquisition by Altaris

      RESEARCH TRIANGLE PARK, N.C., October 06, 2026--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the completion of its acquisition by affiliates of Altaris, LLC ("Altaris"), an investment firm focused exclusively on the healthcare industry.

      Oct 6Yahoo FinanceSLP
      Simulations Plus Says FDA's Cosmetics Branch Adopts ADMET Predictor
      Sep 18Yahoo FinanceSLP
      Simulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science Branch

      RESEARCH TRIANGLE PARK, N.C., September 17, 2026--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that the U.S. Food and Drug Administration’s (FDA) Cosmetics Regulatory Science Branch has licensed ADMET Predictor® to support its computational research for modern cosmetic safety assessment. The contract expands the use of Simulations Plus technolog

      Sep 17Yahoo FinanceSLP
      Simulations Plus Shareholders Approve Merger with Altaris Affiliate

      Detailed price information for Simulations Plus Inc (SLP-Q) from The Globe and Mail including charting and trades.

      Aug 29The Globe and MailSLP

      This is the newest page. Registered accounts read further back.